ALYSSA ACKER: Open Payments
NPI 1316597073 · MOUNT LAUREL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 60 payments from 12 companies in 2025. Trend: 2023 $789 · 2024 $650 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $231 |
| Novartis Pharmaceuticals Corporation | 21 | $186 |
| ABBVIE INC. | 3 | $52 |
| Arcutis Biotherapeutics, Inc. | 3 | $45 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $32 |
| REVANCE THERAPEUTICS, INC. | 1 | $23 |
| Botanix SB Inc | 1 | $21 |
| Organon LLC | 3 | $18 |
| PFIZER INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
Products named: TREMFYA, COSENTYX, Zoryve, SKYRIZI, DAXXIFY, RINVOQ, SOFDRA, Leqselvi.
Industry payments across NJ — which companies pay providers there.
